Skip to main content
FBLG
NASDAQ Life Sciences

FibroBiologics Establishes $6.15M At-The-Market Offering, Exceeding Current Market Cap Amidst Going Concern Warning

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.46
Mkt Cap
$5.129M
52W Low
$1.03
52W High
$22.6
52W Position info
42% above low
Off High info
94% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

FBLG sits 42% above its 52-week low of $1.03.

Summary

FibroBiologics has launched a new At-The-Market offering to sell up to $6.15 million in common stock, an amount greater than its current market capitalization, to address working capital needs following a recent going concern warning.


Key Events · Financing and Capital Events · FBLG

  • New At-The-Market (ATM) Offering

    FibroBiologics entered into an ATM agreement with H.C. Wainwright & Co., LLC to sell up to $6.15 million of common stock from time to time.

  • Significant Potential Dilution

    The maximum offering amount of $6.15 million is greater than the company's current market capitalization, indicating a high potential for substantial dilution to existing shareholders if fully utilized.

  • Addresses Going Concern Warning

    This capital raise follows the company's recent Q1 2026 10-Q filing, which included a going concern warning and a material weakness in internal controls, underscoring the urgent need for financing.

  • Use of Proceeds

    Net proceeds from the ATM offering are expected to be used for working capital and general corporate purposes.


Analysis · FBLG · Life Sciences

FibroBiologics, a micro-cap company, has entered into a new At-The-Market (ATM) offering agreement to potentially sell up to $6.15 million in common stock. This amount significantly exceeds the company's current market capitalization of approximately $5.1 million, indicating a substantial need for capital and a high potential for dilution for existing shareholders. This aggressive capital raise follows closely on the heels of the company's recent Q1 2026 10-Q filing, which disclosed a going concern warning and a material weakness in internal controls, highlighting the critical financial challenges the company faces. While the ATM provides a mechanism to secure necessary working capital and fund general corporate purposes, the sheer scale of the potential offering relative to the company's current valuation suggests a distressed financing scenario.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FBLG was trading at $1.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.1M. The 52-week trading range was $1.03 to $22.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FBLG - Latest Insights

FBLG
Oct 08, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.13
Real-time Price: $0.910 info
Change: -$0.220 (-19%) info
Market Cap: $8.095M info
FBLG
Sep 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $0.910 info
Change: -$0.520 (-36%) info
Market Cap: $8.095M info
FBLG
Sep 17, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $0.910 info
Change: -$0.575 (-39%) info
Market Cap: $8.095M info
FBLG
Sep 15, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $0.910 info
Change: -$0.6379 (-41%) info
Market Cap: $8.095M info
FBLG
Aug 11, 2026, 8:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.910 info
Change: -$0.040 (-4%) info
Market Cap: $8.095M info